Literature DB >> 15269209

Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.

Sudhir Paul1, Sangeeta Karle, Stephanie Planque, Hiroaki Taguchi, Maria Salas, Yasuhiro Nishiyama, Beverly Handy, Robert Hunter, Allen Edmundson, Carl Hanson.   

Abstract

We report the selective catalytic cleavage of the HIV coat protein gp120, a B cell superantigen, by IgM antibodies (Abs) from uninfected humans and mice that had not been previously exposed to gp120. The rate of IgM-catalyzed gp120 cleavage was greater than of other polypeptide substrates, including the bacterial superantigen protein A. The kinetic parameters of gp120 cleavage varied over a broad range depending on the source of the IgMs, and turnover numbers as great as 2.1/min were observed, suggesting that different Abs possess distinct gp120 recognition properties. IgG Abs failed to cleave gp120 detectably. The Fab fragment of a monoclonal IgM cleaved gp120, suggesting that the catalytic activity belongs to the antibody combining site. The electrophoretic profile of gp120 incubated with a monoclonal human IgM suggested hydrolysis at several sites. One of the cleavage sites was identified as the Lys(432)-Ala(433) peptide bond, located within the region thought to be the Ab-recognizable superantigenic determinant. A covalently reactive peptide analog (CRA) corresponding to gp120 residues 421-431 with a C-terminal amidino phosphonate diester mimetic of the Lys(432)-Ala(433) bond was employed to probe IgM nucleophilic reactivity. The peptidyl CRA inhibited the IgM-catalyzed cleavage of gp120 and formed covalent IgM adducts at levels exceeding a control hapten CRA devoid of the peptide sequence. These observations suggest that IgMs can selectively cleave gp120 by a nucleophilic mechanism and raise the possibility of their role as defense enzymes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269209     DOI: 10.1074/jbc.M406719200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

2.  A covalent HIV vaccine: is there hope for the future?

Authors:  Sudhir Paul; Stephanie A Planque; Yasuhiro Nishiyama; Carl V Hanson
Journal:  Future Virol       Date:  2009       Impact factor: 1.831

Review 3.  Antibodies as defensive enzymes.

Authors:  Sudhir Paul; Yasuhiro Nishiyama; Stephanie Planque; Sangeeta Karle; Hiroaki Taguchi; Carl Hanson; Marc E Weksler
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

4.  Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.

Authors:  Gopal Sapparapu; Stephanie A Planque; Yasuhiro Nishiyama; Steven K Foung; Sudhir Paul
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

5.  Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.

Authors:  Stephanie A Planque; Yukie Mitsuda; Vida Chitsazzadeh; Santhi Gorantla; Larisa Poluektova; Yasuhiro Nishiyama; Christina Ochsenbauer; Mary-Kate Morris; Gopal Sapparapu; Carl V Hanson; Richard J Massey; Sudhir Paul
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

6.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 7.  Antibody-Mediated Catalysis in Infection and Immunity.

Authors:  Anthony Bowen; Maggie Wear; Arturo Casadevall
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

8.  A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.

Authors:  Anthony Bowen; Maggie P Wear; Radames J B Cordero; Stefan Oscarson; Arturo Casadevall
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

9.  Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection.

Authors:  Stephanie Planque; Maria Salas; Yukie Mitsuda; Marcin Sienczyk; Miguel A Escobar; Jason P Mooney; Mary-Kate Morris; Yasuhiro Nishiyama; Dipanjan Ghosh; Amit Kumar; Feng Gao; Carl V Hanson; Sudhir Paul
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

10.  Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.

Authors:  Yukie Mitsuda; Stephanie Planque; Mariko Hara; Robert Kyle; Hiroaki Taguchi; Yasuhiro Nishiyama; Sudhir Paul
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.